Sun Pharma Advanced Research Company Limited (NSE:SPARC)

NSE:SPARC Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	19,094	18,792	717.66	755.45	2,388	1,372
Revenue Growth	2855.99%	2518.47%	-5.00%	-68.36%	73.98%	-45.74%
Gross Profit Gross Profit Growth	18,770	18,492	415.66	391.07	2,105	1,137
Operating Income Operating Income Growth	16,175	15,989	-3,341	-4,115	-2,236	-1,961
Net Income Net Income Growth	15,843	15,532	-3,425	-3,872	-2,226	-2,034
Earnings Per Share EPS Growth	48.80	47.86	-10.55	-11.93	-7.82	-7.73
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	380.49	700.82	749.01	1,071	1,322
Outside India Outside India Growth	11	16.84	6.44	1,317	50.21
Total Total Growth	391.48	717.66	755.45	2,388	1,372

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	11.55	11.55	19.64	1,571	4,025	128.89
Total Debt Total Debt Growth	5,593	5,593	2,689	611.51	156.75	792.14
Net Cash (Debt) Net Cash Growth	-5,582	-5,582	-2,670	959.8	3,868	-663.25
Net Cash Growth	-	-	-	-75.19%	-	-
Net Cash Per Share Net Cash Per Share Growth	-17.19	-17.20	-8.23	2.96	13.59	-2.52

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	-2,388	-3,603	-4,292	-691.18	-2,082
Capital Expenditures CapEx Growth	-	-238.31	-103.4	-265.08	-153.87	-326.78
Free Cash Flow Free Cash Flow Growth	-	-2,626	-3,706	-4,557	-845.05	-2,409
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	98.30%	98.41%	57.92%	51.77%	88.14%	82.83%
Operating Margin	84.71%	85.09%	-465.49%	-544.71%	-93.66%	-142.86%
Pretax Margin	82.96%	82.64%	-477.64%	-512.05%	-93.22%	-148.19%
Profit Margin	82.97%	82.65%	-477.26%	-512.56%	-93.22%	-148.20%
FCF Margin	-	-13.98%	-516.45%	-603.21%	-35.39%	-175.53%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	4.03	2.40	-	-	-	-
Forward PE	-	91.22	91.22	91.22	91.22	91.22
PS Ratio	3.34	1.98	66.88	158.21	24.38	58.82

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error